These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38835710)

  • 21. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.
    Krueger JG; Frew J; Jemec GBE; Kimball AB; Kirby B; Bechara FG; Navrazhina K; Prens E; Reich K; Cullen E; Wolk K
    Br J Dermatol; 2024 Jan; 190(2):149-162. PubMed ID: 37715694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRAK4 Is Overexpressed in Hidradenitis Suppurativa Skin and Correlates with Inflammatory Biomarkers.
    McDonald A; Karnik R; Campbell V; Davis J; Chavoshi S; Slavin A; Sharma K; Gollob J; Alavi A
    J Invest Dermatol; 2024 Jul; ():. PubMed ID: 39084489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
    Agnese ER; Tariche N; Sharma A; Gulati R
    Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Narla S; Azzam M; Townsend S; Vellaichamy G; Marzano AV; Alavi A; Lowes MA; Hamzavi IH
    Br J Dermatol; 2021 Jun; 184(6):1004-1013. PubMed ID: 32893875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
    Agarwal P; Lunge SB; Shetty NS; Karagaiah P; Daveluy S; Ortega-Loayza AG; Tzellos T; Szepietowski JC; Zouboulis CC; Grabbe S; Goldust M
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
    Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hidradenitis Suppurativa.
    Jenkins T; Isaac J; Edwards A; Okoye GA
    Dermatol Clin; 2023 Jul; 41(3):471-479. PubMed ID: 37236715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
    Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Therapeutic Approaches and Targets for the Treatment of Hidradenitis Suppurativa.
    Giuffrida R; Cannavò SP; Coppola M; Guarneri C
    Curr Pharm Biotechnol; 2021; 22(1):59-72. PubMed ID: 32368973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm.
    Maronese CA; Moltrasio C; Genovese G; Marzano AV
    Expert Rev Clin Immunol; 2024 May; 20(5):525-545. PubMed ID: 38130204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tunnels in Hidradenitis Suppurativa: Active Inflammatory Entities with Specific Molecular and Genetic Profiles - A Narrative Review.
    Krajewski PK; Szepietowski JC; Martorell A
    Dermatology; 2023; 239(3):323-327. PubMed ID: 36822156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
    Negus D; Ahn C; Huang W
    Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
    Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological development in hidradenitis suppurativa.
    Matusiak Ł; Jemec GB; Szepietowski JC
    Curr Opin Pharmacol; 2019 Jun; 46():65-72. PubMed ID: 31075754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New therapeutic approaches for hidradenitis suppurativa].
    Suppa M; Benhadou F; Daxhelet M; Del Marmol V
    Rev Med Brux; 2018; 39(4):367-371. PubMed ID: 30321002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis.
    Tricarico PM; Boniotto M; Genovese G; Zouboulis CC; Marzano AV; Crovella S
    Front Immunol; 2019; 10():892. PubMed ID: 31105704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Painful hidradenitis suppurativa.
    Smith HS; Chao JD; Teitelbaum J
    Clin J Pain; 2010 Jun; 26(5):435-44. PubMed ID: 20473053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa.
    Bukvić Mokos Z; Miše J; Balić A; Marinović B
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):9-13. PubMed ID: 32650845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.